CoMeal: Copeptin Changes After Food Intake

Sponsor

University Hospital, Basel, Switzerland (Other)

Overall Status

Completed

CT.gov ID

NCT01772914

Collaborator

(none)

Enrollment

Location

Duration (Months)

2.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether copeptin levels are affected by food intake.

Condition or Disease	Intervention/Treatment	Phase
Healthy Adults Copeptin

Study Design

Study Type:

Observational

Actual Enrollment :

30 participants

Observational Model:

Case-Only

Time Perspective:

Prospective

Official Title:

Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test

Study Start Date :

Feb 1, 2013

Actual Primary Completion Date :

Jun 1, 2013

Actual Study Completion Date :

Feb 1, 2014

Outcome Measures

Primary Outcome Measures

Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid [30, 60, 90, 120, 180 minutes after intake of the test liquids]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Aged over 18 years

Exclusion Criteria:

Intake of any kind of medication (except birth control pill)
BMI >30 kg/m2
Evidence of any acute illness
History of chronic illness
Pregnancy
Known galactosemia or maltose malabsorption
Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l